| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 135.19B | 130.64B | 115.81B | 105.00B | 96.07B | 82.45B |
| Gross Profit | 37.59B | 36.10B | 32.40B | 27.13B | 23.95B | 21.69B |
| EBITDA | 14.25B | 18.94B | 16.58B | 12.78B | 12.63B | 10.77B |
| Net Income | 12.24B | 12.18B | 12.31B | 8.65B | 8.17B | 6.30B |
Balance Sheet | ||||||
| Total Assets | 143.52B | 141.56B | 130.53B | 113.00B | 103.70B | 96.91B |
| Cash, Cash Equivalents and Short-Term Investments | 51.87B | 53.41B | 54.24B | 46.39B | 44.16B | 39.92B |
| Total Debt | 39.00M | 42.00M | 0.00 | 0.00 | 1.00M | 1.00M |
| Total Liabilities | 41.20B | 38.35B | 37.70B | 33.09B | 31.79B | 32.21B |
| Stockholders Equity | 101.59B | 102.49B | 92.71B | 79.83B | 71.85B | 64.66B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.11B | 10.28B | 3.54B | 5.47B | 9.60B |
| Operating Cash Flow | 0.00 | 10.38B | 12.58B | 5.51B | 6.57B | 11.18B |
| Investing Cash Flow | 0.00 | -9.52B | -2.87B | -2.26B | -1.50B | -1.65B |
| Financing Cash Flow | 0.00 | -2.13B | -2.29B | -1.24B | -1.06B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥157.04B | 12.20 | ― | 1.94% | 11.63% | 3.32% | |
79 Outperform | ¥11.38B | 10.27 | ― | 2.82% | 7.10% | 18.03% | |
77 Outperform | ¥62.46B | 11.48 | ― | 3.43% | 5.51% | 13.00% | |
75 Outperform | ¥64.67B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
70 Outperform | ¥162.64B | 7.70 | 8.17% | 2.04% | 1.48% | 58.59% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | ¥12.65B | 33.09 | ― | 2.71% | -6.08% | -56.08% |